Shanghai Haihe Pharmaceutical Research and Development Co., Ltd. Witnesses Shift in IPO Review Status to 'Approved'
4 hour ago / Read about 0 minute
Author:小编   

The data furnished by Tonghuashun Information Service is derived from artificial intelligence algorithms. Should any inconsistencies arise, kindly consult the official information disclosure platform designated by the China Securities Regulatory Commission for listed companies.